These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 1343861

  • 21. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
    Uetz-von Allmen E, Sturzenegger M, Rieben R, Rihs F, Frauenfelder A, Nydegger UE.
    Eur Neurol; 1998; 39(2):103-10. PubMed ID: 9520071
    [Abstract] [Full Text] [Related]

  • 22. Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy.
    Bech E, Andersen H, Orntoft TF, Jakobsen J.
    Ann Neurol; 1998 Jan; 43(1):72-8. PubMed ID: 9450770
    [Abstract] [Full Text] [Related]

  • 23. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer.
    Harvey GK, Toyka KV, Zielasek J, Kiefer R, Simonis C, Hartung HP.
    Muscle Nerve; 1995 Apr; 18(4):388-94. PubMed ID: 7715623
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FG.
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [Abstract] [Full Text] [Related]

  • 26. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K, Sonoo M, Ogawa G, Kamakura K, Ueda-Sada M, Arita M, Motoyoshi K, Kusunoki S.
    Neurology; 2008 Nov 18; 71(21):1683-90. PubMed ID: 19015484
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S, Morita D, Ohminami S, Hitoshi S, Kanazawa I.
    Muscle Nerve; 2003 Mar 18; 27(3):302-6. PubMed ID: 12635116
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies.
    Lardone RD, Alaniz ME, Irazoqui FJ, Nores GA.
    J Neuroimmunol; 2006 Apr 18; 173(1-2):174-9. PubMed ID: 16376437
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1.
    Marcus DM, Perry L, Gilbert S, Preud'homme JL, Kyle R.
    J Immunol; 1989 Nov 01; 143(9):2929-32. PubMed ID: 2572647
    [Abstract] [Full Text] [Related]

  • 34. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice.
    Sheikh KA, Zhang G, Gong Y, Schnaar RL, Griffin JW.
    Ann Neurol; 2004 Aug 01; 56(2):228-39. PubMed ID: 15293275
    [Abstract] [Full Text] [Related]

  • 35. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
    Yuki N, Yoshino H, Sato S, Ohno T, Miyatake T.
    Rinsho Shinkeigaku; 1990 Sep 01; 30(9):989-93. PubMed ID: 2265511
    [Abstract] [Full Text] [Related]

  • 36. Cloning of human anti-GM1 antibodies from motor neuropathy patients.
    Willison HJ, Paterson G, Kennedy PG, Veitch J.
    Ann Neurol; 1994 Apr 01; 35(4):471-8. PubMed ID: 8154875
    [Abstract] [Full Text] [Related]

  • 37. [A case of chronic inflammatory demyelinating polyneuropathy with recurrent ophthalmoplegia, persistent conduction block, antibody activity against gangliosides GM1].
    Ryo M, Saito T, Kunii N, Hasegawa H, Kowa H.
    Rinsho Shinkeigaku; 1994 Jul 01; 34(7):702-6. PubMed ID: 7955728
    [Abstract] [Full Text] [Related]

  • 38. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
    Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, Noda M.
    Ann Neurol; 1998 Aug 01; 44(2):202-8. PubMed ID: 9708542
    [Abstract] [Full Text] [Related]

  • 39. Detection of anti-GM1 ganglioside antibodies in patients with neuropathy by a novel latex agglutination assay.
    Alaedini A, Latov N.
    J Immunoassay; 2000 Nov 01; 21(4):377-86. PubMed ID: 11071254
    [Abstract] [Full Text] [Related]

  • 40. T cells from patients with Guillain-Barré syndrome produce interferon-gamma in response to stimulation with the ganglioside GM1.
    McCombe PA, Csurhes PA.
    J Clin Neurosci; 2010 Apr 01; 17(4):537-8. PubMed ID: 20093028
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.